{"id":22090,"date":"2018-09-21T09:52:50","date_gmt":"2018-09-21T09:52:50","guid":{"rendered":"http:\/\/biomedpharmajournal.org\/?p=22090"},"modified":"2020-04-23T11:48:56","modified_gmt":"2020-04-23T11:48:56","slug":"electrospun-ocimum-sanctum-loaded-fibres-with-potential-biomedical-applications-periodontal-therapeutic-perspective","status":"publish","type":"post","link":"https:\/\/biomedpharmajournal.org\/staging\/vol11no3\/electrospun-ocimum-sanctum-loaded-fibres-with-potential-biomedical-applications-periodontal-therapeutic-perspective\/","title":{"rendered":"Electrospun Ocimum Sanctum Loaded Fibres with Potential Biomedical Applications \u2013 Periodontal Therapeutic Perspective"},"content":{"rendered":"

Introduction<\/strong><\/p>\n

Chronic periodontitis is an infectious disease resulting in inflammation within the supporting tissues of the teeth, progressive attachment and bone loss and is characterized by pocket formation and or gingival recession.1<\/sup> It is said to be a localized inflammatory response towards bacterial colonization within the tissues as a result of plaque and calculus accumulation.2<\/sup> In patients with periodontitis, the subgingival plaque and its components activate the host defense mechanisms, but in most cases this defense mechanism is unable to limit or prevent the formation of the microbial plaque.3<\/sup><\/p>\n

Traditionally, periodontal therapy aimed at mechanical debridement, which creates or facilitates a root surface that is devoid of contaminants and helps in new attachment. The inability of mechanical debridement to achieve an ideal root surface, accessibility to deeper pockets and complexity of the microbial population has led to the search for adjunctive therapeutic strategies which will increase the likelihood for the successful management of periodontal pockets.<\/p>\n

Concerns are frequently raised with systemic antibacterial therapy.4<\/sup> The use of synthetic agents give rise to resistant strains and other deleterious effects in the long run. Compared to systemic delivery of drugs, in periodontitis, local drug delivery can be beneficial as it can be used site specifically. The use of natural products has been increasing as it does not pose such concerns that the synthetic agents cause. One such herb, Ocimum sanctum (family:Labiateae) commonly known as \u2018Tulsi\u2019, \u2018Holy Basil\u2019 are known to possess therapeutic potential and has been used for its properties such as\u00a0 antimicrobial, antidiabetic, anticancer, analgesic by traditional practitioners5<\/sup><\/p>\n

Electro spinning, a versatile and cost effective method for nanoscale fiber production has been receiving great attention in recent years. They have various properties such as nano porus structure, large surface to volume ratio, flexibility for physical or chemical modification.6<\/sup><\/p>\n

This study was done with an aim to determine the accurate spinning parameters to incorporate the natural herb Ocimum sanctum (Tulsi) into poly vinyl acetate (PVA) an FDA approved polymer and to analyse the resultant fibres using SEM.<\/p>\n

Materials and Methodology<\/strong><\/p>\n

Ocimum Aanctum (Tulsi) Extract Preparation<\/em><\/strong><\/p>\n

Ocimum sanctum leaf obtained was verified by a botanist. Leaves were separated from the stems and shade dried for 1 week. This was then ground into a fine powder. 50 gm of tulsi powder was dissolved in 500ml methanol(Sigma Aldrich).The methanol solvent was evaporated using Rotary evaporator(BUCHI rotavapor R-200) under reduced pressure to obtain methanol crude extract. It was suspended in different organic solvents hexane and methanol (25 gm each). Both the extracts were filtered through Whatman No.41 filter paper to remove particles. The particle free extract was evaporated completely by using Rotary evaporator (BUCHI rotavapor R-200) under reduced pressure to obtain dry crude extracts. The residue left in the separatory funnel was re-extracted twice and followed the same procedure and filtered. The combined extracts were concentrated and dried by rotary evaporator under reduced pressure7<\/sup><\/p>\n

Preparation of Spinning Solutions<\/em><\/strong><\/p>\n

Polyvinyl Acetate (HIMEDIA)\/Tulsi solutions were prepared by dissolving tulsi in 10% (w\/v) aqueous PVA solution. Solutions were prepared with Tulsi at 1%, 5%,10%,15%,20% wt with respect to PVA content and was placed in a sonicator for 5 minutes and then stirred for 8 hours continuously at room temperature.7,8<\/sup><\/p>\n

Electro Spinning Process<\/em><\/strong><\/p>\n

The parameters of spinning were varied and the resultant fibers were analysed under SEM to identify the accurate parameters for the successful spinning of Ocimum sanctum incorporation in PVA. The different parameters tried were as follows:<\/p>\n

The drug\/ polymer solutions were loaded into a 5 ml syringe. The syringe was fixed horizontally onto a syringe pump (HOLAMRC\u2019S HO-SPLF4) and the solutions were electro spun using a high voltage power supply (Holmarc\u2019s HO-NFES-040). Electro spinning was performed using the following parameters: applied voltage of 13kV, tip- to- collector distance which was set at 12cm, solution flow rate of 500\u00b5l\/hr, tip diameter of 12mm, volume of 2.5ml and duration of 5hours<\/p>\n

The drug\/ polymer solutions were loaded into a 1 ml syringe. The syringe was fixed horizontally onto a syringe pump (HOLAMRC\u2019S HO-SPLF4) and the solutions were electro spun using a high voltage power supply (Holmarc\u2019s HO-NFES-040). Electro spinning was performed using the following parameters: applied voltage of 15kV, tip- to- collector distance which was at 22cm, solution flow rate of 0.8ml\/hr, tip diameter of 22mm, temperature was at 25\u030aC.11<\/sup><\/p>\n

The drug\/ polymer solutions were loaded into a 5 ml syringe. The syringe was fixed horizontally onto a syringe pump (HOLAMRC\u2019S HO-SPLF4) and the solutions were electro spun using a high voltage power supply (Holmarc\u2019s HO-NFES-040). Electro spinning was performed using the following parameters: applied voltage of 15kV, tip- to- collector distance was at 22cm, solution flow rate was kept at 1ml\/hr, tip diameter of 0.91mm, temperature was set at 25\u030aC.12\u00a0<\/sup><\/p>\n

The drug\/ polymer solutions were loaded into a 5 ml syringe. The syringe was fixed horizontally onto a syringe pump (HOLAMRC\u2019S HO-SPLF4) and the solutions were electro spun using a high voltage power supply (Holmarc\u2019s HO-NFES-040). Electro spinning was performed using the following parameters: applied voltage of 20kV, tip- to- collector distance at 16-18.5cm, solution flow rate at 1.5ml\/hr, tip diameter of 0.4mm, temperature was 25\u030aC.13<\/sup><\/p>\n

The drug\/ polymer solutions were loaded into a 5 ml syringe. The syringe was fixed horizontally onto a syringe pump (HOLAMRC\u2019S HO-SPLF4) and the solutions were electro spun using a high voltage power supply (Holmarc\u2019s HO-NFES-040). Electro spinning was performed using the following parameters: applied voltage which was set at 55kV, tip- to- collector distance was 12 cm, solution flow rate was kept at 1.00 ml\/hr, tip diameter was set at 0.4mm, temperature of 20\u030aC.14<\/sup><\/p>\n

Results<\/strong><\/p>\n

Material Characterization<\/strong><\/p>\n

Electro spinning done under the following conditions resulted in formation of uniform and beadless fibers. Applied voltage set at 13kV, tip- to- collector distance of 12cm, solution flow rate of 500\u00b5l\/hr, tip diameter of 12mm, volume of 2.5ml and\u00a0 duration of 5hours.<\/p>\n

The drug loaded fiber morphology was examined by field- emission scanning electron microscopy (SEM) (Quanta 200 FEG). For SEM, Si wafer was the substrate used and Au sputtered onto the specimens to ensure sufficient electrical conductivity.15<\/sup> WD- working distance, larger the working distance greater is depth of field but lesser resolution.<\/p>\n

SEM images revealed that the textures of all resultant samples were homogenous and free of heterogeneities or artefacts\u2019. 10wt% fibers seem to have smooth surface with no visible beading.<\/p>\n

The parameters, such as the polymer drug composition, voltage, electrode distance, temperature or humidity, were individually and precisely adjusted in order to produce structures that were as similar as possible. Incorporation of tulsi in PVA has resulted in fibers having thin diameters thereby increasing surface area.<\/p>\n\n\n\n
\"Figure<\/td>\n\n

Figure 1: 5% concentration of tulsi in PVA, the fibres showed no obvious artefacts or heterogeneities. The fiberes distribution\u00a0 seemed scanty.<\/strong><\/p>\n

Click here to view figure<\/a><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n\n\n\n
\u00a0\"Figure<\/td>\n\n

Figure 2: 10% concentration of Tulsi in PVA showed homogeneous and uniform fibers with no visible heterogeneities or artefacts.<\/strong><\/p>\n

Click\u00a0here to\u00a0view\u00a0figure<\/a><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n\n\n\n
\"Figure<\/td>\n\n

Figure 3: 20% concentration of tulsi in PVA, the fiberes seemed to be dense in distribution.<\/strong><\/p>\n

Click\u00a0here to\u00a0view\u00a0figure<\/a><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Discussion<\/strong><\/p>\n

After optimization, electro spinning of PVA nanofibers containing tulsi was successfully done. Electro spinning is a rapid and efficient process that can be used to incorporate various drugs and polymers in a random fashion or a predetermined and well defined axis.18<\/sup><\/p>\n

Our experiment demonstrated that it is possible to tailor the parameters such that desirable fibers are produced. Electro spinning has proven itself as a very effective method for the fabrication of drug loaded fibers. The three main reasons for the use of PVA as the polymer was because of its resorbable nature, approved for medical purpose and its mechanical stability. The mechanical stability of the fiber mats is important such that it has to resist the mechanical stress caused by the sulcus fluid. There has been a rising interest in electro spinning membranes as a method of polymer-fiber processing for various bio-medical applications with drug release.19<\/sup><\/p>\n

As long as a polymer can be electro spun into nanofibers, ideal outcome would be in that the diameters of the fibres are consistent and controllable, the fiber surface is defect-free and continuous single nano fibers are collectable.20<\/sup> Increased surface area results in larger quantities of drug being dispersed.21<\/sup> The fiber diameter is seen to increase with the increase in concentration of the spinning solution. 20% showed higher fiber diameter\u00a0 than 5, 10%.22<\/sup><\/p>\n

The parameters known to influence the spinning properties are viscosity, elasticity, conductivity and surface tension of the spinning solution. The hydrostatic pressure in the capillary tube, electric potential at the capillary tip, the distance between the tip and the collector, temperature, humidity and air velocity in the spinning chamber.23<\/sup><\/p>\n

Study done by Markus Reise et al, by incorporating metronidazole in Poly (L-lactide-co-D\/L-lactide) by electro spinning for the treatment of local periodontitis showed that, under the parameters chosen, fibers had a smooth structure. The amount of metronidazole incorporated had an influence on the fiber diameter, higher concentration showed larger fiber diameters.8<\/sup> This is in accordance with the results obtained in our study. Xiao- Zhu Sun et al did a study by incorporating curcumin in PVA by electro spinning at 5%,10%,15% and 20% concentrations.5% weight showed smooth surface under SEM whereas \u201dbead on string\u201d were observed with higher drug loading. Beads increased as the concentration of curcumin was higher which may be due to the low solubility of curumin which caused the aggregation in the spinning solution.6<\/sup> Suitable selection of the solvent is an important aspect in successful preparation of electro spun polymer nanofiber and drug loaded nanofibers.23<\/sup><\/p>\n

Study done by Shen X et al by incorporating Diclofenac sodium (Eudagrit\u00ae L 100-55 ) at 9.1%,16.7%,33.3% showed that 9.1% and 16.7% had almost the same fiber diameter, but as the drug concentration was increased, not only did the diameter increase but also smooth surface of the fibers were lost as seen from the SEM imaging. It could be said that as the \u00a0concentration of diclofenac increased, the viscosity if the solution increases, this counteracted the conductivity.20<\/sup><\/p>\n

In a study done by Hongxu et al, with an aim of Encapsulation of Drug Reservoirs in fibers by Emulsion Electro spinning and to characterize its Morphology and assess the Preliminary Release, the results obtained showed smooth fibers, having an average size of 2.21(1.15 \u00b5m)could be achieved by electro spinning from Poly-L-lactic acid \u00a0solution with the addition of the surfactant Sodium bis (2-ethyl hexyl) sulfosuccinate. From their study it was seen that the flow of the emulsion through a long capillary and when it forms rapidly expanding and bending fluid jets, the dispersed phase shows a tendency to accumulate at the centre of the liquid for the elongation effect along the direction of fluid during its flight in the air. Thus the micro beads settle into fibers than at the centre2<\/sup><\/p>\n

From the various studies seen, it can be seen that concentration plays an important role in the nature of the \ufb01bres obtained. Electro spinning of Diclofenac Sodium containing PVA solutions resulted in the formation of beaded \ufb01bres, whereas 10% w\/v PVA solution resulted in cross-sectional round \ufb01bres with smooth surface, as seen in the study done by Taepaiboon et al23<\/sup> Decreased surface tension favoured the formation of bead-free \ufb01bres.24<\/sup><\/p>\n

Conclusion<\/strong><\/p>\n

From this study, we can conclude that the fabrication of a smooth nanofiber system which is incorporated with the natural herb tulsi is possible. Although further investigations are needed in regard to the release pattern and sustainability of the agent. Thus electro spinning of Ocimum sanctum incorporated in PVA is a promising area in future development of drug delivery using natural products incorporated within polymers.<\/p>\n

References<\/strong><\/p>\n

    \n
  1. American Academy of Periodontology, editor. Glossary of periodontal terms. American Academy of Periodontology. 2001.<\/li>\n
  2. Haffajee A.D and Socransky S.S. Attachment level changes in destructive periodontal diseases. J. Clin. Periodonto<\/em>. 1986;13:461\u2013472.
    \n    CrossRef<\/a><\/li>\n
  3. Darveau R.P, Tanner A, Page R.C.\u00a0 The microbial challenge in periodontitis. Periodontology<\/em>. 2000. 1997 Jun 1;14(1):12-32.
    \n    CrossRef<\/a><\/li>\n
  4. Krayer J.W, Leite R. S & Kirkwood K. L. Non-Surgical Chemotherapeutic Treatment Strategies for the Management of Periodontal Diseases.\u00a0Dental Clinics of North America<\/em>. 2010;54(1):13\u201333.
    \n    CrossRef<\/a><\/li>\n
  5. Sen P. Therapeutic potentials of tulsi: From experience to facts. Drugs, news & views. 1993;2:15-21.<\/li>\n
  6. Sun X.Z, Williams G.R, Hou X.X, Zhu L.M.\u00a0 Electrospun curcumin-loaded fibers with potential biomedical applications. Carbohydrate polymers.<\/em> 2013 Apr 15;94(1):147-53.
    \n    CrossRef<\/a><\/li>\n
  7. Hossain M.A, Al-Hdhrami S.S, Weli A.M, Al-Riyami Q, Al-Sabahi J.N. Isolation, fractionation and identification of chemical constituents from the leaves crude extracts of Mentha piperita L grown in Sultanate of Oman. Asian Pacific journal of tropical biomedicine.<\/em> 2014 May 31;4:368-72.
    \n    CrossRef<\/a><\/li>\n
  8. Reise M, Wyrwa R, M\u00fcller U, Zylinski M, V\u00f6lpel A, Schnabelrauch M, Berg A, Jandt K.D, Watts D.C, Sigusch B.W.\u00a0 Release of metronidazole from electrospun poly (L-lactide-co-D\/L-lactide) fibers for local periodontitis treatment. Dental Materials.<\/em> 2012 Feb 29;28(2):179-88.
    \n    CrossRef<\/a><\/li>\n
  9. Jannesari M, Varshosaz J, Morshed M, Zamani M. Composite poly (vinyl alcohol)\/poly (vinyl acetate) electrospun nanofibrous mats as a novel wound dressing matrix for controlled release of drugs. International journal of nanomedicine<\/em>. 2011;6:993.<\/li>\n
  10. Taepaiboon P, Rungsardthong U, Supaphol P. Drug-loaded electrospun mats of poly (vinyl alcohol) fibres and\u00a0 their release characteristics of four model drugs. Nanotechnology. 2006 Apr 11;17(9):2317.
    \n    CrossRef<\/a><\/li>\n
  11. Reise M, Wyrwa R, M\u00fcller U, Zylinski M, V\u00f6lpel A, Schnabelrauch M, Berg A, Jandt K.D, Watts D.C, Sigusch B.W.\u00a0 Release of metronidazole from electrospun poly (L-lactide-co-D\/L-lactide) fibers for local periodontitis treatment. Dental Materials.<\/em> 2012 Feb 29;28(2):179-88.
    \n    CrossRef<\/a><\/li>\n
  12. Zeng J, Aigner A, Czubayko F, Kissel T, Wendorff J.H, Greiner A. Poly (vinyl alcohol) nanofibers by electrospinning as a protein delivery system and the retardation of enzyme release by additional polymer coatings. Biomacromolecules.<\/em> 2005 May 9;6(3):1484-8.
    \n    CrossRef<\/a><\/li>\n
  13. Hrib J, Sirc J, Hobzova R, Hampejsova Z, Bosakova Z, Munzarova M & Michalek J. Nanofibers for drug delivery \u2013 incorporation and release of model molecules, influence of molecular weight and polymer structure.\u00a0Beilstein Journal of Nanotechnology<\/em>. 2015;6:1939\u20131945.
    \n    CrossRef<\/a><\/li>\n
  14. Shenoy S.L, Bates W.D, Wnek G.\u00a0 Correlations between electrospinnability and physical gelation. Polymer<\/em>. 2005 Oct 7;46(21):8990-9004.
    \n    CrossRef<\/a><\/li>\n
  15. Jannesari M, Varshosaz J, Morshed M, Zamani M. Composite poly (vinyl alcohol)\/poly (vinyl acetate) electrospun nanofibrous mats as a novel wound dressing matrix for controlled release of drugs. International journal of nanomedicine.<\/em> 2011;6:993.<\/li>\n
  16. Sill T.J, von Recum H. A.\u00a0 Electrospinning: Applications in Drug Delivery and Tissue Engineering. Biomaterials<\/em>. 2008;29:1989\u20132006.
    \n    CrossRef<\/a><\/li>\n
  17. Moghe A.K, Gupta B.S. Co\u2010axial electrospinning for nanofiber structures: preparation and applications. Polymer Reviews<\/em>. 2008 May 1;48(2):353-77.
    \n    CrossRef<\/a><\/li>\n
  18. Doshi D.H.\u00a0RenekerElectro spinning process and applications of electrospun fibers. J Electrostatics<\/em>. 1995;35(2-3):151-160.
    \n    CrossRef<\/a><\/li>\n
  19. Shen X, Yu D, Zhu L, Branford-White C, White K, Chatterton N.P. Electrospun diclofenac sodium loaded Eudragit\u00ae L 100-55 nanofibers for colon-targeted drug delivery. International journal of pharmaceutics<\/em>. 2011 Apr 15;408(1):200-7.
    \n    CrossRef<\/a><\/li>\n
  20. Matthews J.A, Wnek G.E, Simpson D.G, Bowlin G.L. Electrospinning of collagen nanofibers. Biomacromolecules<\/em>. 2002 Mar 11;3(2):232-8.
    \n    CrossRef<\/a><\/li>\n
  21. Huang Z.M, Zhang Y.Z, Kotaki M, Ramakrishna S. A review on polymer nanofibers by electrospinning and their applications in nanocomposites. Composites science and technology.<\/em> 2003 Nov 30;63(15):2223-53.
    \n    CrossRef<\/a><\/li>\n
  22. Qi H, Hu P, Xu J, Wang A. Encapsulation of drug reservoirs in fibers by emulsion electrospinning: morphology characterization and preliminary release assessment. Biomacromolecules<\/em>. 2006 Aug 14;7(8):2327-30.
    \n    CrossRef<\/a><\/li>\n
  23. Taepaiboon P, Rungsardthong U, Supaphol P. Drug-loaded electrospun mats of poly (vinyl alcohol) fibres and their release characteristics of four model drugs. Nanotechnology. 2006 Apr 11;17(9):2317.
    \n    CrossRef<\/a><\/li>\n
  24. Fong H, Chun I, Reneker D.H. Beaded nanofibers formed during electrospinning. Polymer<\/em>. 1999 Jul 31;40(16):4585-92.
    \n    CrossRef<\/a><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

    Introduction Chronic periodontitis is an infectious disease resulting in inflammation […]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[59],"tags":[],"class_list":["post-22090","post","type-post","status-publish","format-standard","hentry","category-vol11no3"],"_links":{"self":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts\/22090","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/comments?post=22090"}],"version-history":[{"count":5,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts\/22090\/revisions"}],"predecessor-version":[{"id":32526,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts\/22090\/revisions\/32526"}],"wp:attachment":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/media?parent=22090"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/categories?post=22090"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/tags?post=22090"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}